New drop to clear conjunctivitis

New drop to clear conjunctivitis By the third quarter of 2007, a new treatment for bacterial conjunctivitis will be available from Inspire Pharmaceuticals. AzaSite (azithromycin ophthalmic solution) 1% has been approved by the FDA and, according to the manufacturer, will offer patients a reduced dosing regimen compared with other available products for treating the condition. One drop twice-daily for two days, followed by one drop once-daily for the next five days, for a total of nine drops in the affected eye, is the recommended dosing schedule.

To see more Hot off the Press news articles, click here.

Internal server error